⌘K

Login Start Free

Home/Filings/4/0001829126-25-007373

4//SEC Filing

Owens David 4

Accession 0001829126-25-007373

CIK 0001527352other

View on SEC.gov Company Profile

Filed

Sep 11, 8:00 PM ET

Accepted

Sep 12, 5:08 PM ET

Size

7.3 KB

Accession

0001829126-25-007373

Insider Transaction Report

Form 4

Period: 2025-09-12

Nexalin Technology, Inc.NXL

DirectorChief Medical Officer

Transactions

Award
Stock Option (right to buy)
2025-09-12+100,000→ 1,484,809 total
Exercise: $0.96From: 2025-09-12Exp: 2030-08-29→ Common Stock (100,000 underlying)
Award
Stock Option (right to buy)
2025-09-12+203,125→ 1,384,809 total
Exercise: $0.96From: 2025-09-12Exp: 2030-08-29→ Common Stock (203,125 underlying)

Documents

1 file

4
ownership.xmlPrimary
FORM 4

Issuer

Nexalin Technology, Inc.

CIK 0001527352

Entity typeother

Related Parties

1

filerCIK 0001916664

Filing Metadata

Form type: 4
Filed: Sep 11, 8:00 PM ET
Accepted: Sep 12, 5:08 PM ET
Size: 7.3 KB

View on SEC.gov